Determination of urinary oligosaccharides by high-performance liquid chromatography/electrospray ionization-tandem mass spectrometry: Application to Hunter syndrome

Analytical Biochemistry

Volumn 402, Issue 2, 2010, Pages 113-120

  Nielsen, Timothy C ^a   Rozek, Tomas ^a   Hopwood, John J ^a,b   Fuller, Maria ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Dermatan sulfate; Glycosaminoglycans; Heparan sulfate; HPLC; Mass spectrometry; Mucopolysaccharidosis II

Indexed keywords

DIAGNOSIS; DISEASE CONTROL; ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBIC CHROMATOGRAPHY; MASS SPECTROMETRY; NEGATIVE IONS; SULFUR COMPOUNDS;

DERMATAN SULFATE; GLYCOSAMINOGLYCANS; HEPARAN SULFATES; HPLC; MUCOPOLYSACCHARIDOSIS II;

OLIGOSACCHARIDES;

DERMATAN SULFATE; HEPARAN SULFATE; OLIGOSACCHARIDE;

ADOLESCENT; ADULT; ARTICLE; CARBOHYDRATE ANALYSIS; CHILD; CONTROLLED STUDY; DERIVATIZATION; DISEASE COURSE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUNTER SYNDROME; NEUROPATHOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCHOOL CHILD; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION PROCESS;

EID: 77953082989     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.04.002     Document Type: Article

References (32)

1. Kjellen L., Lindahl U. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 1991, 60:443-475.
2. Sugahara K., Kitagawa H. Heparin and heparan sulfate biosynthesis. IUBMB Life 2002, 54:163-175.
3. Trowbridge J.M., Gallo R.L. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 2002, 12:117R-125R.
4. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 1998, 67:609-652.
5. Bernfield M., Götte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 1999, 68:729-777.
6. Kitagawa H., Kinoshita A., Sugahara K. Microanalysis of glycosaminoglycan-derived disaccharides labelled with the fluorophore 2-aminoacridone by capillary electrophoresis and high-performance liquid chromatography. Anal. Biochem. 1995, 232:114-121.
7. Volpi N. Hyaluronic acid and chondroitin sulfate unsaturated disaccharides analysis by high-performance liquid chromatography and fluorimetric detection with dansylhydrazine. Anal. Biochem. 2000, 277:19-24.
8. Koketsu M., Linhardt R.J. Electrophoresis for the analysis of acidic oligosaccharides. Anal. Biochem. 2000, 283:136-145.
9. Imanari T., Toida T., Koshiishi I., Toyoda H. High-performance liquid chromatographic analysis of glycosaminoglycan-derived oligosaccharides. J. Chromatogr. A 1996, 720:275-293.
10. Zaia J. Mass spectrometry of oligosaccharides. Mass Spectrom. Rev. 2004, 23:161-227.
11. Behr J.R., Matsumoto Y., White F.M., Sasisekharan R. Quantification of isomers from a mixture of twelve heparin and heparan sulfate disaccharides using tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19:2553-2562.
12. Ramsay S.L., Meikle P.J., Hopwood J.J. Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry. Mol. Genet. Metab. 2003, 78:193-204.
13. Fuller M., Meikle P.J., Hopwood J.J. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I. Glycobiology 2004, 14:443-450.
14. Fuller M., Chau A., Nowak R.C., Hopwood J.J., Meikle P.J. A defect in exodegradative pathways provides insight into endodegradation of heparan and dermatan sulfates. Glycobiology 2006, 16:318-325.
15. Nielsen T.C., Meikle P.J., Hopwood J.J., Fuller M. Minimum substrate requirements of endoglycosidase activities toward dermatan sulfate by electrospray ionization-tandem mass spectrometry. Glycobiology 2008, 18:1119-1128.
16. Zamfir A., Seidler D.G., Kresse H., Peter-Katalinic J. Structural investigation of chondroitin/dermatan sulfate oligosaccharides from human skin fibroblast decorin. Glycobiology 2003, 13:733-742.
17. Zamfir A., Seidler D.G., Schonherr E., Kresse H., Peter-Katalinic J. On-line sheathless capillary electrophoresis/nanoelectrospray ionization-tandem mass spectrometry for the analysis of glycosaminoglycan oligosaccharides. Electrophoresis 2004, 25:2010-2016.
18. Miller M.J., Costello C.E., Malmstrom A., Zaia J. A tandem mass spectrometric approach to determination of chondroitin/dermatan sulfate oligosaccharide glycoforms. Glycobiology 2006, 16:502-513.
19. Yang H.O., Gunay N.S., Toida T., Kuberan B., Yu G., Kim Y.S., Linhardt R.J. Preparation and structural determination of dermatan sulfate-derived oligosaccharides. Glycobiology 2000, 10:1033-1039.
20. Korir A.K., Larive C.K. Advances in the separation, sensitive detection, and characterization of heparin and heparan sulfate. Anal. Bioanal. Chem. 2009, 393:155-169.
21. Mason K.E., Meikle P.J., Hopwood J.J., Fuller M. Characterization of sulfated oligosaccharides in mucopolysaccharidosis type IIIA by electrospray ionization mass spectrometry. Anal. Chem. 2006, 78:4534-4542.
22. de Agostini A.I., Dong J.C., de Vantery Arrighi C., Ramus M.A., Dentand-Quadri I., Thalmann S., Ventura P., Ibecheole V., Monge F., Fischer A.M., HajMohammadi S., Shworak N.W., Zhang L., Zhang Z., Linhardt R.J. Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity. J. Biol. Chem. 2008, 283:28115-28124.
23. Wu Z.L., Lech M. Characterizing the non-reducing end structure of heparan sulfate. J. Biol. Chem. 2005, 280:33749-33755.
24. Oguma T., Tomatsu S., Montano A.M., Okazaki O. Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry. Anal. Biochem. 2007, 368:79-86.
25. Barroso B., Didraga M., Bischoff R. Analysis of proteoglycans derived sulphated disaccharides by liquid chromatography/mass spectrometry. J. Chromatogr. A 2005, 1080:43-48.
26. Zaia J. On-line separations combined with MS for analysis of glycosaminoglycans. Mass Spectrom. Rev. 2009, 28:254-272.
27. Honda S., Akao E., Suzuki S., Okuda M., Kakehi K., Nakamura J. High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1-phenyl-3-methyl-5-pyrazolone derivatives. Anal. Biochem. 1989, 180:351-357.
28. Naggar E.F., Costello C.E., Zaia J. Competing fragmentation processes in tandem mass spectra of heparin-like glycosaminoglycans. J. Am. Soc. Mass Spectrom. 2004, 15:1534-1544.
29. Neufeld E.F., Muenzer J. The mucopolysaccharidoses. The Metabolic and Molecular Bases of Inherited Disease 2001, 3421-3452. McGraw-Hill, New York. eighth ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
30. Alessio L., Berlin A., Dell'Orto A., Toffoletto F., Ghezzi I. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int. Arch. Occup. Environ. Health 1985, 55:99-106.
31. Boeniger M.F., Lowry L.K., Rosenberg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am. Ind. Hyg. Assoc. J. 1993, 54:615-627.
32. Freeman C., Hopwood J. Lysosomal degradation of heparin and heparan sulphate. Adv. Exp. Med. Biol. 1992, 313:121-134.